| Literature DB >> 29813057 |
Jeffrey R Donowitz1,2, Heather Cook3, Masud Alam4, Fahmida Tofail5, Mamun Kabir4, E Ross Colgate6, Marya P Carmolli6, Beth D Kirkpatrick6, Charles A Nelson7,8, Jennie Z Ma9, Rashidul Haque4, William A Petri1.
Abstract
BACKGROUND: Previous studies have shown maternal, inflammatory, and socioeconomic variables to be associated with growth and neurodevelopment in children from low-income countries. However, these outcomes are multifactorial and work describing which predictors most strongly influence them is lacking. METHODOLOGY/PRINCIPALEntities:
Mesh:
Year: 2018 PMID: 29813057 PMCID: PMC5993301 DOI: 10.1371/journal.pntd.0006363
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Variables measured in the PROVIDE study utilized in random forests models to predict linear growth and Bayley-III neurodevelopmental scores at two years of age.
| - Expenditure | -Activin | -Alpha-1 antitrypsin | -Anti-LPS Ab | -Mannitol Recovery | -CMV IgG positivity at week 40 |
| -Gender | -Anti-LPS Ab | -Calprotectin | -Days of Diarrhea | -Elevated CRP index (measured at 6, 18, 40, 53 weeks) | |
| -Income | -Ferritin | -Mannitol Recovery | -Days of exclusive breastfeeding through 18 weeks | -Rotarix vaccination (given at 10 and 17 weeks) | |
| -LAZ | -RBP | -Myeloperoxidase | -Ferritin | ||
| -Maternal Education | -Reg 1b | -Neopterin | -IL-10 | ||
| -Mother’s Height at enrollment | -sCD14 | -Reg 1b | -IL-1b | ||
| -Mother’s Weight at enrollment | -Vitamin D | -IL-4 | |||
| -Open drain outside the home | -Zinc | -IL-5 | |||
| -Septic Tank/Toilet | -IL-6 | ||||
| -Shared Toilet | -IL-7 | ||||
| -Water treatment | -MIP1b | ||||
| -WAZ | -RBP | ||||
| -WHZ | -sCD14 | ||||
| -TNFα | |||||
| -Vitamin D | |||||
| -Zinc |
Enrollment characteristics of children who completed 2 year anthropomorphic assessments compared with those who did not.
| Variable | Children with Incomplete Data for Anthropometry at 2 years (n = 290) | Children with Complete Data for Anthropometry at 2 years (n = 371) | p value |
|---|---|---|---|
| WAZ at Enrollment | -1.3 ± 0.8 | -1.3 ± 0.8 | 0.31 |
| LAZ at Enrollment | -0.9 ± 0.9 | -0.9 ± 0.4 | 0.80 |
| WHZ at Enrollment | -1.3 ± 0.9 | -1.3 ± 0.9 | 0.14 |
| Age at Enrollment (days) | 4.8 ± 1.7 | 5.1 ± 1.6 | 0.09 |
| Vaccinated with Rotarix | 131 (45.2) | 193 (52.0) | 0.08 |
| Any Maternal Education | 223 (76.9) | 347 (66.6) | 0.004 |
| Expenditure (taka) | 11,607 ± 7833 | 11,529 ± 6,742 | 0.63 |
| Income (taka) | 13,104 ± 10,981 | 12,621 ± 8,093 | 0.64 |
| Mother’s Weight at Enrollment (kg) | 49.4 ± 9.7 | 49.2 ± 9.2 | 0.91 |
| Mother’s Height at Enrollment (cm) | 150.3 ± 5.7 | 150.4 ± 5.4 | 0.61 |
| Male | 164 (56.6) | 188 (51.7) | 0.13 |
| Treated Water | 170 (58.6) | 233 (62.8) | 0.27 |
| Septic Tank/Toilet | 147 (50.7) | 197 (53.1) | 0.54 |
| No Shared Toilet | 247 (85.2) | 317 (85.4) | 0.99 |
| No Open Drain Outside Home | 118 (40.7) | 149 (40.2) | 0.89 |
Data are expressed in mean ± SD for continuous measures and count (%) for discrete measures. P values calculated by Mann-Whitney U test for continuous variables and χ2 test for discrete variables.
* 1 USD = approximately 80.5 Taka
Fig 1Anthropometry over the first 2 years of life for the 371 children with complete anthropometric measurements.
Height and weight were taken at 3-month intervals and transformed to standardized Z scores. The X-axis depicts the child’s age while the Y-axis depicts the percentage of children in the cohort who had a LAZ, WAZ, or WHZ <-2 SD.
Fig 2Random forests plots of the top 15 variables selected for linear growth and performance on the Bayley-III scales of infant and Toddler Development.
Random forests models were constructed for LAZ at two years (A), the change in LAZ from enrollment to two years (B), and Bayley-III scores at two years of age. The Bayley-III is comprised of 4 components, namely cognitive (C), language (D), motor (E), and social-emotional (F). Color-coding correlates to the three clusters identified when all variables were analyzed using Pearson’s correlation (S1 Fig).
Variables selected by both random forest (top 10 selected variables) and SCAD (all selected variables) analyses for the outcomes of linear growth and performance on the Bayley III scales of infant and Toddler Development.
| Mother’s Weight | 1.00 | Mother’s weight | (+) |
| LAZ at Enrollment | 0.57 | LAZ at Enrollment | (+) |
| Mannitol Recovery at week 12 | 0.15 | Expenditure | (+) |
| Mother’s Height | 0.13 | Alpha-1 Antitrypsin at week 12 | (+) |
| Income | 0.11 | IL 4 at week 18, >75%ile | (+) |
| RBP at week 18 | 0.10 | IL 4 at week 18, 50–75%ile | (+) |
| WAZ at Enrollment | 0.09 | IL 10 at week 18, >75%ile | (+) |
| Expenditure | 0.07 | IL 10 at week 18, 50–75%ile | (+) |
| Alpha-1 Antitrypsin at week 12 | 0.06 | Calprotectin at week 12 | (+) |
| Treated Water | 0.04 | ||
| LAZ at Enrollment | 1.00 | LAZ at Enrollment | (-) |
| Mother’s Weight | 0.33 | Mother’s weight | (+) |
| WAZ at Enrollment | 0.22 | Expenditure | (+) |
| Expenditure | 0.13 | IL 4 at week 18, >75%ile | (+) |
| Income | 0.09 | IL 4 at week 18, 50–75%ile | (+) |
| Septic Tank/Toilet | 0.07 | Calprotectin at week 12 | (+) |
| IL 4 at week 18 | 0.05 | Alpha-1 Antitrypsin at week 12 | (+) |
| Days of Diarrhea at week 18 | 0.04 | ||
| Mannitol Recovery at week 12 | 0.03 | ||
| Neopterin at week 12 | 0.02 | ||
| WAZ at Enrollment | 1.00 | WAZ at Enrollment | (+) |
| Income | 0.77 | Income | (+) |
| LAZ at Enrollment | 0.71 | TNFα at week 18, >75%ile | (-) |
| TNFα at week 18 | 0.41 | TNFα at week 18, 50–75%ile | (+) |
| Expenditure | 0.36 | sCD14_at week 18 | (-) |
| sCD14 at week 18 | 0.33 | Ferritin at week 18 | (+) |
| Ferritin at week 18 | 0.27 | IL 7 at week 18, >75%ile | (-) |
| Mother’s Weight | 0.13 | IL 7 at week 18, 50–75%ile | (-) |
| IL 7 at week 18 | 0.13 | No Maternal Education | (-) |
| No Maternal Education | 0.08 | Anti-LPS Ab at week 18 | (-) |
| Anti-LPS Ab at week 6 | (-) | ||
| Male | (-) | ||
| Calprotectin at week 12 | (-) | ||
| Neopterin at week 12 | (+) | ||
| Rotarix | 1.00 | Rotarix | (+) |
| IL 5 at week 18 | 0.87 | IL 5 at week 18, >75%ile | (+) |
| sCD14 at week 18 | 0.75 | IL 5 at week 18, 50–75%ile | (+) |
| Mother’s Weight | 0.64 | sCD14 at week 18 | (-) |
| TNFα at week 18 | 0.63 | Mother’s weight | (+) |
| Male | 0.60 | TNFα at week 18, >75%ile | (-) |
| WHZ at Enrollment | 0.56 | TNFα at week 18, 50–75%ile | (+) |
| Expenditure | 0.50 | Male | (-) |
| CRP Index | 0.46 | No Maternal education | (-) |
| Activin at week 6 | 0.41 | WAZ at Enrollment | (+) |
| Income | (+) | ||
| Calprotectin at week 12 | (-) | ||
| MPO at week 12 | (-) | ||
| Ferritin at week 6 | (+) | ||
| Calprotectin at week 12 | 1.00 | Calprotectin at week 12 | (-) |
| WAZ at Enrollment | 0.95 | WAZ at Enrollment | (+) |
| Neopterin at week 12 | 0.79 | Neopterin at week 12 | (+) |
| CRP Index | 0.68 | TNFα at week 18, >75%ile | (-) |
| TNFα at week 18 | 0.56 | TNFα at week 18, 50–75%ile | (+) |
| Days of Diarrhea at week 18 | 0.51 | IL 5 at week 18, >75%ile | (-) |
| IL 5 at week 18 | 0.50 | IL 5 at week 18, 50–75%ile | (+) |
| sCD14 at week 18 | 0.49 | sCD14 at week 18 | (-) |
| Alpha-1 Antitrypsin at week 12 | 0.47 | No Maternal education | (-) |
| Mannitol Recovery at week 12 | 0.40 | Income | (+) |
| Reg1B at week 6 | (-) | ||
| Anti-LPS Ab at week 18 | (-) | ||
| MPO at week 12 | (+) | ||
| Vit D at week 6 | (+) | ||
| Mother’s weight | (+) | ||
| Ferritin at week 18 | (+) | ||
| IL 7 at week 18, >75%ile | (-) | ||
| IL 7 at week 18, 50–75%ile | (-) | ||
| sCD14 at week 18 | 1.00 | sCD14 at week 18 | (-) |
| Income | 0.95 | Income | (+) |
| WAZ at Enrollment | 0.77 | WAZ at Enrollment | (+) |
| LAZ at Enrollment | 0.69 | TNFα at week 18, >75%ile | (-) |
| TNFα at week 18 | 0.47 | TNFα at week 18, 50–75%ile | (+) |
| Treated Water | 0.38 | Treated Water | (+) |
| Calprotectin at week 12 | 0.37 | Calprotectin at week 12 | (-) |
| Expenditure | 0.29 | Vit D at week 6 | (+) |
| Vitamin D at week 6 | 0.25 | Zinc at week 6 | (-) |
| Zinc at week 18 | 0.24 | Mother’s height | (+) |
| No Maternal education | (-) | ||
| Male | (-) | ||
| RBP at week 18 | (-) | ||
| Mannitol Recovery at week 12 | (-) | ||
*Only the top 10 variables shown